Jade Biosciences (JBIO) Cash & Current Investments (2020 - 2026)

Jade Biosciences' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $311.3 million for Q1 2026.

• Quarterly Cash & Current Investments rose 308.47% year-over-year to $311.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $311.3 million (up 308.47% YoY) and the FY2025 annual result came in at $336.2 million, up 384.48% from the prior year.
• Cash & Current Investments was $311.3 million for Q1 2026 at Jade Biosciences, down from $336.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $336.2 million in Q4 2025 and bottomed at $59.6 million in Q2 2022.
• A 5-year average of $153.7 million and a median of $129.2 million in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments sank 56.45% — and 2025, when it soared 384.48%.
• Jade Biosciences' Cash & Current Investments stood at $129.2 million in 2022, then retreated by 5.25% to $122.4 million in 2023, then tumbled by 43.33% to $69.4 million in 2024, then surged by 384.48% to $336.2 million in 2025, then decreased by 7.4% to $311.3 million in 2026.
• Business Quant data shows JBIO's Cash & Current Investments at $311.3 million in Q1 2026, $336.2 million in Q4 2025, and $198.9 million in Q3 2025.